4796-07-0

Basic information

• Product Name: 1-(4-butoxyphenyl)propan-2-one
• CAS NO: 4796-07-0
• Molecular Formula: C₁₃H₁₈O₂
• Molecular Weight: 206.2808
• Mol File: 4796-07-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 302.1°C at 760 mmHg
• Flash Point: 122°C
• Density: 0.985g/cm³
• Vapor Pressure: 0.00101mmHg at 25°C
• Refractive Index: 1.494
• CAS DataBase Reference: 1-(4-butoxyphenyl)propan-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-butoxyphenyl)propan-2-one(4796-07-0)
• EPA Substance Registry System: 1-(4-butoxyphenyl)propan-2-one(4796-07-0)

Safety Data

• Hazardous Substances Data: 4796-07-0(Hazardous Substances Data)

Usage

Physical state

Yellow liquid

Odor

Fruity, floral

Uses

a. Fragrance ingredient in consumer products (perfumes, personal care products)
b. Chemical intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds

Potential properties

a. Antifungal
b. Antimicrobial

Safety considerations

Handle with caution and follow proper safety procedures due to potential health hazards if not used properly.

Upstream product

• 4796-06-9 butyl-[4-(2-nitro-cis-propenyl)-phenyl]-ether 
• 4796-06-9 1-(p-Butoxyphenyl)-2-nitro-1-propen 
• 4547-57-3 4-butoxyphenylacetic acid 
• 917-54-4 methyllithium 
• 156-38-7 4-hydroxyphenylacetate 
• 5736-88-9 p-butoxybenzaldehyde 
• 770-39-8 4-methoxyphenylacetone 

Downstream Products

• 4796-09-2 3-(4-butoxy-phenyl)-4-methyl-pentan-2-one 
• 125960-46-5 2-Butoxy-5-(2-oxo-propyl)-benzenesulfonamide 
• 144818-28-0 2-n-Butoxy-5-[2-[2-(5-fluoro-2-methoxyphenoxy)ethylamino]-propyl]benzenesulfonamide 

Relevant articles and documents

Rational design, synthesis and structure-activity relationships of 4-alkoxy- and 4-acyloxy-phenylethylenethiosemicarbazone analogues as novel tyrosinase inhibitors

In continuing our program aimed to search for potent compounds as highly efficient tyrosinase inhibitors, here a series of novel 4-alkoxy- and 4-acyloxy-phenylethylenethiosemicarbazone analogues were designed, synthesized and their biological activities on mushroom tyrosinase were evaluated. Notably, most of compounds displayed remarkable tyrosinase inhibitory activities with IC50 value of lower than 1.0 μM. Furthermore, the structure-activity relationships (SARs) were discussed and the inhibition mechanism and the inhibitory kinetics of selected compounds 7k and 8d were also investigated. Taken together, these results suggested that such compounds could serve as the promising candidates for the treatment of tyrosinase-related disorders and further development of such compounds might be of great interest.